CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer

被引:0
|
作者
Tucker, John B. [1 ]
Carlsen, Caleb L. [2 ]
Scribano, Christina M. [3 ]
Pattaswamy, Srishrika M. [4 ]
Burkard, Mark E. [5 ,6 ,7 ]
Weaver, Beth A. [4 ,5 ,7 ]
机构
[1] Univ Wisconsin Madison, Canc Biol Grad Training Program, Madison, WI USA
[2] Univ Wisconsin Madison, Cellular & Mol Biol Grad Training Program, Madison, WI USA
[3] Univ Wisconsin Madison, Cellular & Mol Pharmacol Grad Training Program, Madison, WI USA
[4] Univ Wisconsin Madison, Dept Cell & Regenerat Biol, Madison, WI USA
[5] Univ Wisconsin, Dept Oncol, McArdle Lab Canc Res, Madison, WI USA
[6] Univ Wisconsin Madison, Dept Med, Madison, WI USA
[7] Univ Wisconsin Madison, Carbone Canc Ctr, Madison, WI USA
关键词
PHASE-II TRIAL; PROTEIN-E; INDIVIDUAL MICROTUBULES; SPINDLE MULTIPOLARITY; SUPPRESSES DYNAMICS; CELL-PROLIFERATION; ERIBULIN MESYLATE; MITOTIC ARREST; BI; 2536; TAXOL;
D O I
10.1158/0008-5472.CAN-23-3332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The increased incidence of polar chromosomes induced by inhibition of the mitotic kinesin CENP-E exacerbates chromosomal instability, reduces daughter cell viability, and improves sensitivity to microtubule-targeting therapies. Drugs that perturb microtubules are commonly used to treat breast cancers of all subtypes in both early stage and metastatic disease, but they are effective in only approximately 50% of patients. High concentrations of microtubule-targeting agents can elicit mitotic arrest in cell culture models; however, recent evidence from primary and metastatic breast cancers has revealed that these agents only accumulate at intratumoral levels capable of inducing abnormal multipolar mitotic spindles, not mitotic arrest. Although the maintenance of multipolar spindles can generate cytotoxic rates of chromosomal instability (CIN), focusing of aberrant multipolar spindles into normal bipolar spindles can dramatically reduce CIN and confer resistance to microtubule poisons. Here, we showed that inhibition of the mitotic kinesin centromeric-associated protein-E (CENP-E) overcomes resistance caused by focusing multipolar spindles. Clinically relevant microtubule-targeting agents used a mechanistically conserved pathway to induce multipolar spindles without requiring centrosome amplification. Focusing could occur at any point in mitosis, with earlier focusing conferring greater resistance to antimicrotubule agents. CENP-E inhibition increased CIN on focused spindles by generating chromosomes that remained misaligned at spindle poles during anaphase, which substantially increased death in the resulting daughter cells. CENP-E inhibition synergized with diverse, clinically relevant microtubule poisons to potentiate cell death in cell lines and suppress tumor growth in orthotopic tumor models. These results suggest that primary resistance to microtubule-targeting drugs can be overcome by simultaneous inhibition of CENP-E.Significance: The increased incidence of polar chromosomes induced by inhibition of the mitotic kinesin CENP-E exacerbates chromosomal instability, reduces daughter cell viability, and improves sensitivity to microtubule-targeting therapies.
引用
收藏
页码:2674 / 2689
页数:16
相关论文
共 15 条
  • [1] Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E
    Putkey, FR
    Cramer, T
    Morphew, MK
    Silk, AD
    Johnson, RS
    McIntosh, JR
    Cleveland, DW
    DEVELOPMENTAL CELL, 2002, 3 (03) : 351 - 365
  • [2] Unstable kinetochore-microtubule capture and chromosomal instability following deletion of CENP-E
    Putkey, FR
    Cramer, T
    Morphew, MK
    Silk, AD
    Johnson, RS
    McIntosh, JR
    Cleveland, DW
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 175A - 175A
  • [3] Epothilones - a new class of microtubule-targeting agents in the treatment of breast cancer
    Wysocki, Piotr J.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2008, 12 (08): : 343 - 348
  • [4] Markers predicting clinical benefit in breast cancer from microtubule-targeting agents
    Pusztai, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 15 - 20
  • [5] Differential Sensitivity of Breast Cancer Cell Lines to Diverse Microtubule Targeting Agents
    Risinger, A. L.
    Dybdal-Hargreaves, N.
    Mooberry, S. L.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [6] HPV16 E6 Induces Chromosomal Instability due to Misaligned Chromosomes Caused by E6AP-Dependent Degradation of the Mitotic Kinesin CENP-E
    Cosper, P.
    Funk, L.
    Lee, D.
    Paracha, M.
    Kimple, R. J.
    Lambert, P.
    Weaver, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S155 - S156
  • [7] HPV16 E6 induces chromosomal instability due to polar chromosomes caused by E6AP-dependent degradation of the mitotic kinesin CENP-E
    Cosper, Pippa F.
    Hrycyniak, Laura C. F.
    Paracha, Maha
    Lee, Denis L.
    Wan, Jun
    Jones, Kathryn
    Bice, Sophie A.
    Nickel, Kwangok
    Mallick, Samyukta
    Taylor, Alison M.
    Kimple, Randall J.
    Lambert, Paul F.
    Weaver, Beth A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (14)
  • [8] AMG 900, a Small-Molecule Inhibitor of Aurora Kinases, Potentiates the Activity of Microtubule-Targeting Agents in Human Metastatic Breast Cancer Models
    Bush, Tammy L.
    Payton, Marc
    Heller, Scott
    Chung, Grace
    Hanestad, Kelly
    Rottman, James B.
    Loberg, Robert
    Friberg, Gregory
    Kendall, Richard L.
    Saffran, Douglas
    Radinsky, Robert
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11) : 2356 - 2366
  • [9] Design, synthesis, and evaluation of anti-breast cancer activity of colchicine - combretastatin A-4 analogues containing quinoline as microtubule-targeting agents
    Doan, Nam Q. H.
    Tran, Hoan N.
    Nguyen, Nhu T. M.
    Nguyen, Khang D. T.
    Tao, Vu M.
    Lai, Nhu N.
    Tran, Huong T. T.
    Luu, Phu H. T.
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1312
  • [10] Evaluation of Synergy Between Novel PI3K-pathway Inhibitors and Microtubule-targeting Agents in HER2-negative Breast Cancer
    Gris-Oliver, A.
    Oliveira, M.
    Piris, A.
    Saura, C.
    Cortes, J.
    Serra, V.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S213 - S213